Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

Abstract

The prognosis of type 1 autoimmune hepatitis on adequate immunosuppressive treatment improves when the serum alanine aminotransferase level persists at < or = 40 IU/L. Factors existing prior to medical treatment may not affect the prognosis.